BSEInsider Trading / SAST2d ago · 28 Sept 2026, 05:30 pm
Closure of Trading Window
Sangam Health Care Products Ltd · 531625
✦ AI Summary
Sangam Health Care Products Ltd has announced the closure of its trading window from 1st October 2026, which will reopen after 48 hours from the declaration of unaudited financial results for the quarter and half year ending 30.09.2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sangam Health Care Products Ltd - 531625 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
13338ed5-c5ee-471f-9db7-a46e93c0e249.pdf
View document text
To, Date: 28.09.2026
The Manager
BSE Limited,
P.J. Towers, Dalal Street,
Mumbai - 400001.
Scrip Code: 531625
Dear Sir/Madam,
Sub: Closure of Trading Window
Unit: Sangam Health Care Products Ltd
We would like to inform you that as per the Company's minimum Standards Code of Conduct to
regulate, monitor and report trading by its Employees and other Connected Persons under SEBI
(Prohibition of Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider
Trading) (Amendment) Regulations, 2018 and pursuant to BSE Circular Ref No:
LIST/COMP/01/2019-20 dated 02nd April, 2019 on the provisions of Clause 4 of the Schedule B of
the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain
closed on and from 1st October, 2026 and will re-open after completion of 48 hours from the
declaration of Un Audited Financial Results for the quarter and half year ending 30.09.2026 by the
Board of Directors of the Company.
Accordingly, all the Designated Persons and their immediate relatives are being intimated not to
enter into any transaction involving dealing/trading in shares of the Company during the aforesaid
period of closure of Trading Window
Further the date of Board Meeting for considering the said Un audited Financial results for the
quarter and half year ended 30.09.2026 shall be intimated in due course.
This is for the information and records of the Exchange, please.
Thanking you.
Yours Faithfully
For Sangam Health Care Products Limited
D Bhagat Reddy
Managing Director
DIN: 07087331
CC: To all the Designated Employees / Directors /Officers